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Exercise in Claudicants is Accompanied by Excessive
Thrombin Generation
P. Burns1, T. Wilmink1, C. Fegan2 and A. W. Bradbury1
1University Department of Vascular Surgery and 2Department of Haematology, Heartlands Hospital, Birmingham
Background: exercise in IC leads to ischaemia-reperfusion injury of leg muscles and a systemic inflammatory response, but
the effect of on coagulation is unknown.
Objective: to compare the effect of exercise on thrombin formation and fibrin turnover in patients with IC (n 10), and age
and sex matched smokers ([S] n 5) and non-smokers ([NS] n 5) without peripheral vascular disease.
Methods: blood was taken from subjects 60 and 30 min before, and 1, 5, 20, 40, 60 and 120 min after, treadmill exercise.
Markers of thrombin generation (thrombin-antithrombin complexes [TAT] and prothrombin fragments 1 2 [PF1 2])
and fibrin turnover (D-dimer and fibrin degradation products [FbDP]) were assayed at each time point.
Results: following exercise, thrombin generation was significantly greater in the claudicant group compared to the control
groups (Area Under Curve [AUC] post exercise IC vs S vs NS; TAT 3960 vs 1623 vs 1476 vs 0.007 Kruskal±Wallis
[KW]; PF1 2 163 vs 107 vs 123 p 0.024 KW). Pre and post-exercise, fibrin turnover in claudicants was similar to
smoking controls, but higher than non-smoking controls. (AUC post exercise IC vs NS; D-dimer 6340 vs 2754 p 0.055
Mann±Whitney U[MW}; FbDP 45113 vs 21511 p 0.009 MW).
Conclusion: when compared to non-claudicants, exercise in IC is associated with excessive production of thrombin. Despite
this, claudicants have a similar level of fibrin turnover suggesting a possible defect in fibrinolysis. This prothrombotic state
may contribute to the excess thrombotic morbidity and mortality suffered by claudicants.
Key Words: Coagulation; Claudication; Ischaemia-reperfusion.
Introduction
Intermittent claudication affects 5% of the middle-
aged (55±75 years) European population. While only
1±2% claudicants progress to critical limb ischaemia
each year, they suffer an annual cardiovascular mor-
tality that is 3±4 times greater than that observed in an
age and sex matched non-claudicant population.1
Although this may simply reflect the burden of
multi-system atherosclerosis, even when the extent of
concomitant coronary and extracranial vascular dis-
ease is taken into account, claudicants still appear to
suffer an excess of thrombotic vascular events.2 The
reasons for this remain ill-defined. However, several
groups have shown that when claudicants walk and
then rest they suffer repeated episodes of leg muscle
ischaemia- and reperfusion injury (IRI), which in turn
leads to the development of a systemic inflammatory
response (SIR). It has been suggested that this SIR
injures the endothelium, accelerates atherosclerosis
and may increase thrombotic risk.3 However, to date,
the effect of exercise in claudicants on haemostasis has
not been adequately defined. The aim of the present
study, therefore, was to compare the effect of treadmill
exercise on thrombin production and fibrin turnover
in claudicants and controls without peripheral arterial
disease (PAD).
Methods
Ten smoking male claudicants and 10 aged-matched
(3 years) male controls (five smoking, five non-
smoking) without PAD were recruited (see Table 1
for inclusion and exclusion criteria and Table 2 for
baseline patient and control characteristics). To avoid
walking patients were transported to hospital by
taxi, and then to a quiet, temperature-controlled
(25±28 C) room within the Vascular Studies Unit
(VSU) by wheelchair. Subjects were asked to abstain
from smoking, or eating a heavy meal for 1 h prior
to arrival, and avoid unaccustomed exercise in the
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p = 0.005 †† 
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p = 08 †.
p = 0.009††
























p = 0.109† 
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could be harmful. Worryingly, while exercise therapy
has been shown to reduce mortality in patients with
coronary artery disease, no such benefit has yet been
demonstrated in patients with PAD.13 At present the
effect of revascularisation, either by means of angio-
plasty or bypass, on the prothrombotic diathesis
observed in the present study is unknown. However,
one could hypothesise that by restoring normal arter-
ial flow and abolishing calf muscle IRI, such proce-
dures might ameliorate SIRS and the haemostatic
changes seen with exercise seen in patients treated
medically. We are currently examining these issues
within the confines of the U.K.-based, multi-centre,
Exercise versus Angioplasty in Claudication Trial
(EXACT) where claudicants are being randomised to
BMT, BMT plus angioplasty and BMT plus supervised
exercise. By combining data from these basic science
and clinical studies it should be possible to tailor
therapy to the individual patient in order to maximise
safety, clinical and cost-effectiveness.
In conclusion, exercise in claudicants is associated
with excessive thrombin generation, which is not seen
in non-claudicants. Further work is required to deter-
mine whether this has long-term clinical conse-
quences or should influence management.
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